Le Lézard
Classified in: Health
Subject: PDT

InventHelp Inventor Develops New Pain Relief Pad (CNC-1012)


PITTSBURGH, July 2, 2024 /PRNewswire/ -- "I'm a nurse and I thought there could be a better way to apply Epsom salt to help relieve pain and inflammation," said an inventor, from Charlotte, N.C., "so I invented the INFLAMMATION BE- GONE PAD. My design can easily and neatly be applied to the area requiring attention."

The patent-pending invention provides relief from inflammation and pain. In doing so, it could be easily applied to any area of the body, such as the hands, arms, stomach, and legs. It also could offer heating and/or cooling capabilities, and it helps reduce mess and odors associated with traditional ointments. The invention features an effective design that is easy to use so it is ideal for individuals who experience pain, athletes, post-surgical patients, etc. Additionally, it is producible in various sizes and includes heating/cooling options as well as adhesive/non-adhesive options.

The original design was submitted to the Charlotte sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 22-CNC-1012, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com. 

SOURCE InventHelp


These press releases may also interest you

at 15:04
/C O R R E C T I O N -- Menarini Silicon Biosystems/
In the news release, Menarini's cell based non-invasive prenatal technology demonstrates high resolution detection of fetal genomic abnormalities from a simple maternal blood draw, issued 02-Jul-2024 by Menarini Silicon Biosystems over PR Newswire,...

at 14:53
Alzheimer's Association Welcomes U.S. FDA Approval of Kisunla (donanemab)
The Alzheimer's Association celebrates today's U.S. Food and Drug Administration (FDA) action to approve Kisunlatm (donanemab, Eli Lilly) for the treatment of people living with early symptomatic Alzheimer's disease, which includes mild cognitive...

at 14:45
Alleva Recognized in Software Advice FrontRunners for HIPAA Compliance Software Report 2024
Alleva, a premier provider of electronic medical record (EMR) software solutions tailored for the behavioral health and addiction recovery sectors, is proud to announce its inclusion in the Software Advice FrontRunners for HIPAA Compliance Software...

at 14:37
The Association for Diagnostics & Laboratory Medicine (formerly AACC) supports Rep. Cassidy's letter asking the FDA to explain how it plans to abide by the recent Supreme Court decision curtailing the power of federal agencies
Statement attributable to:Octavia Peck Palmer, PhDPresident, Association for Diagnostics & Laboratory Medicine (formerly AACC) "On June 28, in Loper Bright Enterprises v. Raimondo, the Supreme Court overturned the so-called Chevron doctrine and...

at 14:24
NanoCellect Launches VERLO: First Demonstration of Image-Based Sorting of Interacting Immune Synapsed Cells Followed by Confirmation of Immune Functionality
NanoCellect Biomedical, a leader in microfluidic cell sorting technology, proudly announces the launch of VERLOtm Image-Guided Cell Sorter, a groundbreaking cell sorter poised to redefine the landscape of single-cell visualization and gentle flow...

at 14:00
Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders, announced today...

More news about Health...


News published on and distributed by: